2 completed, 1 terminated, 1 unknown. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Sodium Chloride Injection: new trials by email Literature Review of Sodium Chloride Injection trials Research Report on Sodium Chloride Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery Meloxicam Injection, Sodium Chloride Injection - Participants With Acute Moderate to Severe Pain Following Abdominal Surgery | Phase 3 | Completed | Yangtze River Pharmaceutical Group Co., Ltd. | 224 | 2024-01-29 | 2025-04-01 |
| Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis Interferon, Sodium Hyaluronate, Sodium Chloride Injection - Interstitial Cystitis | Phase 2 / Phase 3 | Unknown | West China Hospital | 129 | 2023-10-15 | 2023-09-15 |
| Controlling Rapid Atrial Fibrillation With Dexmedetomidine Dexmedetomidine Hydrochloride, Normal Saline - Rapid Atrial Fibrillation, Heart Rate Control | Phase 2 / Phase 3 | Terminated | Stony Brook University | 13 | 2019-08-21 | 2024-06-04 |
| Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer Placebos, Sulijia - Advanced Non-small Cell Lung Cancer | Phase 3 | Completed | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | 560 | 2011-11-10 | 2017-04-17 |
Atrial Fibrillation (1) · Carcinoma, Non-Small-Cell Lung (1) · Cystitis, Interstitial (1)
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. (1) · Stony Brook University (1) · West China Hospital (1) · Yangtze River Pharmaceutical Group Co., Ltd. (1)
China (2) · United States (1)
Andreas Kalogeropoulos, MD MPH PhD (1) · Wei-min Li (1) · Yuankai Shi, M.D. (1)